Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results

ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with Geographic Atrophy; Company to Engage Regulatory Agencies to Determine Optimal Path Forward ...

Related Keywords

United States ,Brisbane ,Queensland ,Australia ,American ,Chelcie Lister ,Sheryl Seapy ,Jamie Dananberg ,American Society Of Retina Specialists ,Strategic Communications ,Nasdaq ,Securities Exchange ,Leadership Team ,Company To ,Annexon Inc ,Company To Provide Updates ,Results Presented ,Demonstrate Preservation ,Visual Function ,Geographic Atrophy ,Engage Regulatory Agencies ,Determine Optimal Path ,Key Catalysts Expected ,Second Half ,Including Completion ,Provide Updates Across ,Complement Therapies During Rd Day ,Financial Position ,Operating Runway ,Douglas Love ,Highlights Potential ,Differentiated Treatment ,Path Forward ,American Society ,Retina Specialists ,Chief Medical Officer ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Private Securities Litigation Reform Act ,Consolidated Statements ,Markets ,